alpha-Pyrrolidinobutiophenone

α-Pyrrolidinobutiophenone (α-PBP) is a stimulant compound developed in the 1960s[2] which has been reported as a novel designer drug. It can be thought of as the homologue lying between the two better known drugs α-PPP and α-PVP.

alpha-Pyrrolidinobutiophenone
Legal status
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class B
  • US: Schedule I [1]
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H19NO
Molar mass217.306 g/mol g·mol−1
3D model (JSmol)
 NY (what is this?)  (verify)

Legality

In the United States, it is a Schedule I controlled substance.[3]

Sweden's public health agency suggested to classify α-PBP as hazardous substance on November 10, 2014.[4]

As of October 2015 α-PBP is a controlled substance in China.[5]

See also

References
  1. "Lists of: Scheduling Actions, Controlled Substances, Regulated Chemicals" (PDF). U.S. Department of Justice, Drug Enforcement Administration, Office of Diversion Control. Retrieved 30 August 2014.
  2. Ernst Seeger. α-Pyrrolidinyl ketones. US Patent 3314970
  3. Schedules of Controlled Substances: Temporary Placement of 10 Synthetic Cathinones Into Schedule I
  4. "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 29 June 2015.
  5. "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.